Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 Diagnostic performance of serum GM, BALF GM, smear/culture, mNGS

From: Impact of physician awareness and microbiological examination on incidence of COVID-19-associated pulmonary aspergillosis: a retrospective study

 

Count of sample

Count of positives

Sensitivity

BALF GM

50

39

78.00%

mNGS

42

30

71.43%

serum GM

86

42

48.84%

BALF culture

51

23

45.10%

sputum culture

91

36

39.56%

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us